Filtros de búsqueda

Lista de obras de Gary C Starling

A phase I study of CR002, a fully-human monoclonal antibody against platelet-derived growth factor-D

artículo científico publicado en 2008

Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule

article

Analysis of the ligand binding site in Fas (CD95) by site-directed mutagenesis and comparison with TNFR and CD40

artículo científico publicado en 1998

Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis

artículo científico publicado en 2006

BTNL8, a butyrophilin-like molecule that costimulates the primary immune response

artículo científico publicado en 2013

Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Non-Human Primates of the Anti-PD-1 Antibody Pembrolizumab

artículo científico publicado en 2020

CD6-ligand interactions: a paradigm for SRCR domain function?

artículo científico publicado en 1997

Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.

artículo científico publicado en 1996

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model.

artículo científico publicado en 2009

Elotuzumab directly enhances NK cell cytotoxicity against myeloma via CS1 ligation: evidence for augmented NK cell function complementing ADCC.

artículo científico publicado en 2013

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways

artículo científico publicado en 2014

Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells

artículo científico publicado en 2017

Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships.

artículo científico publicado en 2005

Identification of a circulating soluble form of CD80: levels in patients with hematological malignancies

artículo científico publicado en 2004

Identification of the tumor antigen 90K domains recognized by monoclonal antibodies SP2 and L3 and preparation and characterization of novel anti-90K monoclonal antibodies

scientific article published on 01 March 1997

Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death.

artículo científico publicado en 2000

Intercellular adhesion molecule-3 is the predominant co-stimulatory ligand for leukocyte function antigen-1 on human blood dendritic cells

artículo científico publicado en 1995

Isolation of human blood dendritic cells by discontinuous Nycodenz gradient centrifugation

artículo científico publicado en 1995

Molecular cloning of a novel member of the immunoglobulin gene superfamily homologous to the polymeric immunoglobulin receptor

artículo científico publicado el 1 de mayo de 1992

Nuclear Factor κB is Required for Tumor Growth Inhibition Mediated by Enavatuzumab (PDL192), a Humanized Monoclonal Antibody to TweakR.

artículo científico publicado en 2014

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

scientific article published on January 2013

Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome

artículo científico publicado en 2004

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

artículo científico publicado en 2001

The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site

artículo científico publicado en 1995

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda